Serina Therapeutics, Inc. Interest Expense Nonoperating
Serina Therapeutics, Inc. (SER) reported Interest Expense Nonoperating of $203.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- Serina Therapeutics, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $203.00K, a 2155.56% increase year-over-year.
- Serina Therapeutics, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $189.00K.
- Serina Therapeutics, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $198.00K, a 1064.71% increase year-over-year.
- Serina Therapeutics, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $6.00K, a 62.50% decline year-over-year.
- Serina Therapeutics, Inc. interest expense nonoperating for fiscal 2025 was $213.00K, a 59.51% decline from fiscal 2024.
- Serina Therapeutics, Inc. interest expense nonoperating for fiscal 2024 was $526.00K, a 5.73% decline from fiscal 2023.
- Serina Therapeutics, Inc. interest expense nonoperating for fiscal 2023 was $558.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 6 month as first filed | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $203.00K 10-Q · filed 2026-08-13 | $392.00K 10-Q · filed 2026-08-13 | $590.00K derived: sum of 3 quarters · filed 2026-08-13 | $596.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $189.00K 10-Q · filed 2026-05-14 | $387.00K derived: sum of 2 quarters · filed 2026-05-14 | $393.00K derived: sum of 3 quarters · filed 2026-05-14 | $402.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $204.00K derived: sum of 2 quarters · filed 2026-03-25 | $213.00K derived: sum of 3 quarters · filed 2026-08-13 | $213.00K 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-13 | $15.00K derived: sum of 2 quarters · filed 2026-08-13 | $15.00K 10-Q · filed 2025-11-13 | $32.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $9.00K 10-Q · filed 2026-08-13 | $9.00K 10-Q · filed 2026-08-13 | $26.00K derived: sum of 3 quarters · filed 2026-08-13 | $42.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $17.00K derived: sum of 2 quarters · filed 2026-05-14 | $33.00K derived: sum of 3 quarters · filed 2026-05-14 | $340.00K derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $33.00K derived: sum of 2 quarters · filed 2026-03-25 | $340.00K derived: sum of 3 quarters · filed 2026-03-25 | $526.00K 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $16.00K 10-Q · filed 2025-11-13 | $323.00K derived: sum of 2 quarters · filed 2025-11-13 | $509.00K 10-Q · filed 2025-11-13 | $685.00K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $307.00K 10-Q · filed 2025-08-11 | $242.00K 10-Q · filed 2024-08-09 | $493.00K 10-Q · filed 2025-08-11 | $341.00K 10-Q · filed 2024-08-09 | $669.00K derived: sum of 3 quarters · filed 2025-08-11 | $769.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $186.00K 10-Q · filed 2025-05-08 | $362.00K derived: sum of 2 quarters · filed 2025-05-08 | $462.00K derived: sum of 3 quarters · filed 2025-05-08 | $570.00K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $276.00K derived: sum of 2 quarters · filed 2025-03-24 | $384.00K derived: sum of 3 quarters · filed 2025-03-24 | $558.00K 10-K · filed 2025-03-24 | ||
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-12 | $208.00K derived: sum of 2 quarters · filed 2024-11-12 | $382.00K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $108.00K 10-Q · filed 2024-08-09 | $194.00K 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |